Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine in Parkinson's disease
RBR-5nryr5Completed
- Sponsor
- Universidade Federal de Santa Maria
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of duloxetine in Parkinson's disease (PD), sponsored by Universidade Federal de Santa Maria. Started Dec 2017; status: completed.
02
Drugs
duloxetine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on RBR-5nryr5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-5nryr5.